...
首页> 外文期刊>European journal of pharmaceutical sciences >Characterization of thermal and rheological properties of zidovidine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.
【24h】

Characterization of thermal and rheological properties of zidovidine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.

机译:齐多替定,拉米夫定和增塑剂与乙基纤维素共混物的热和流变特性的表征,以评估其对热熔挤出的适用性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The influence of antiretroviral drugs and plasticizers on the rheological and thermal characteristics of ethyl cellulose formulations intended for hot melt extrusion has been investigated. Antiretroviral drugs used were zidovudine and lamivudine, whilst plasticizers included triethylcitrate (TEC) and polyethylene glycol (PEG-6000). Physical mixtures containing ethyl cellulose with varying concentrations of drugs and plasticizers were characterized using differential scanning calorimetry (DSC) and parallel plate oscillatory rheometry. The viscosity of physical mixtures containing both drugs was lower than observed for pure ethyl cellulose, indicating that the drugs had a plasticizing effect. This was confirmed by lowering of the glass transition temperature (Tg) of ethyl cellulose. At the highest loading of 40% by weight, lamivudine appeared to become saturated within the polymer, causing an increase in viscosity and showing evidence of recrystallization upon cooling. Both TEC and PEG-6000 were found to lower the Tg of ethyl cellulose, although PEG-6000 recrystallized upon cooling which makes it unsuitable for use in the proposed controlled release formulations. Both plasticizers were also shown to reduce the viscosity of ethyl cellulose, more significantly so for TEC. The results indicate that ethyl cellulose formulations containing up to 40% by weight of zidovudine, not more than 30% by weight of lamivudine, with 5-10% by weight of TEC as the plasticizer are suitable for processing by hot melt extrusion.
机译:研究了抗逆转录病毒药物和增塑剂对拟用于热熔挤出的乙基纤维素制剂的流变学和热学特性的影响。使用的抗逆转录病毒药物是齐多夫定和拉米夫定,而增塑剂包括柠檬酸三乙酯(TEC)和聚乙二醇(PEG-6000)。使用差示扫描量热法(DSC)和平行板振荡流变法对含有乙基纤维素以及不同浓度的药物和增塑剂的物理混合物进行了表征。包含两种药物的物理混合物的粘度低于纯乙基纤维素的粘度,表明药物具有增塑作用。这通过降低乙基纤维素的玻璃化转变温度(Tg)来确认。在40重量%的最高负载下,拉米夫定似乎在聚合物内饱和,导致粘度增加并显示出冷却后重结晶的迹象。发现TEC和PEG-6000均可降低乙基纤维素的Tg,尽管PEG-6000冷却后会重结晶,这使其不适用于建议的控释制剂。还显示两种增塑剂均降低乙基纤维素的粘度,对于TEC则更明显。结果表明,含有高达40重量%的齐多夫定,不超过30重量%的拉米夫定和5-10重量%的TEC作为增塑剂的乙基纤维素制剂适合于通过热熔挤出加工。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号